Johnson & Johnson: A Dividend Growth Gem
publication date: Oct 16, 2015
Johnson & Johnson continues to grow on an operational basis, and its pharmaceutical pipeline may offer huge rewards in coming years. We’re huge fans of its financial profile and lofty dividend coverage.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.